DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding DiaMedica Therapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 88 | −9 |
| Shares | 11.7M | 875.2K | 12.5M | +1.65M (+15.2%) |
| Value | $79.2M | $5.93M | $87.8M | +$14.6M (+19.9%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 145,247 | $1.02M | 0.00% |
| Cobalt Capital Management, Inc. | 90,000 | $633.6K | 0.45% |
| Diametric Capital, LP | 76,621 | $539.4K | 0.06% |
| Ballentine Partners, LLC | 41,012 | $288.7K | 0.00% |
| HSBC Holdings PLC | 34,224 | $244.7K | 0.00% |
| XTX Topco Ltd | 15,096 | $106.3K | 0.00% |
| Persistent Asset Partners Ltd | 2,613 | $18.4K | 0.01% |
| Steward Partners Investment Advisory, LLC | 1,500 | $10.6K | 0.00% |
| Aquatic Capital Management LLC | 11 | $77 | 0.00% |
| SRS Capital Advisors, Inc. | 8 | $56 | 0.00% |
Sold out (19)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| First Manhattan Co | 455,000 | $3.08M |
| SEI Investments Co | 111,320 | $753.6K |
| EAM Investors, LLC | 91,425 | $618.9K |
| Kalehua Capital Management LLC | 62,488 | $423.0K |
| ExodusPoint Capital Management, LP | 60,011 | $406.3K |
| Renaissance Technologies LLC | 52,523 | $355.6K |
| Quadrature Capital Ltd | 22,039 | $149.2K |
| Susquehanna International Group, LLP | 21,650 | $146.6K |
| Perigon Wealth Management, LLC | 13,957 | $94.5K |
| Colony Group, LLC | 12,993 | $88.0K |
| Qube Research & Technologies Ltd | 10,881 | $73.7K |
| Tocqueville Asset Management L.P. | 10,500 | $71.1K |
| Capital & Planning, LLC | 2,001 | $13.5K |
| Group One Trading, L.P. | 1,342 | $9.09K |
| Pension & Wealth Management Advisors, Inc. | 400 | $2.71K |
| YANKCOM Partnership | 200 | $1.35K |
| MAI Capital Management | 9 | $61 |
| Rothschild Investment LLC | 3 | $20 |
| Essential Partners LLC | 2 | $14 |
Not filed for Q2 2026 yet (2)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Paragon Associates & Paragon Associates II Joint Venture | 875,000 | $5.92M |
| CWM, LLC | 199 | $1.35K |